Related Experiment Video
Updated: Jul 15, 2025

Assessing Urinary Tract Junction Obstruction Defects by Methylene Blue Dye Injection
Published on: October 12, 2017
Mouse and human studies support DSTYK loss of function as a low-penetrance and variable expressivity risk factor for
Jeremiah Martino1, Qingxue Liu1, Katarina Vukojevic2
1Department of Medicine, Columbia University Irving Medical Center, New York, NY.
Purpose:
Previous work identified rare variants in DSTYK associated with human congenital anomalies of the kidney and urinary tract (CAKUT). Here, we present a series of mouse and human studies to clarify the association, penetrance, and expressivity of DSTYK variants.
Methods:
We phenotypically characterized Dstyk knockout mice of 3 separate inbred backgrounds and re-analyzed the original family segregating the DSTYK c.654+1G>A splice-site variant (referred to as "SSV" below). DSTYK loss of function (LOF) and SSVs were annotated in individuals with CAKUT, epilepsy, or amyotrophic lateral sclerosis vs controls. A phenome-wide association study analysis was also performed using United Kingdom Biobank (UKBB) data.
Results:
Results demonstrate ∼20% to 25% penetrance of obstructive uropathy, at least, in C57BL/6J and FVB/NJ Dstyk-/- mice. Phenotypic penetrance increased to ∼40% in C3H/HeJ mutants, with mild-to-moderate severity. Re-analysis of the original family segregating the rare SSV showed low penetrance (43.8%) and no alternative genetic causes for CAKUT. LOF DSTYK variants burden showed significant excess for CAKUT and epilepsy vs controls and an exploratory phenome-wide association study supported association with neurological disorders.
Conclusion:
These data support causality for DSTYK LOF variants and highlights the need for large-scale sequencing studies (here >200,000 cases) to accurately assess causality for genes and variants to lowly penetrant traits with common population prevalence.
Insights
Rare DSTYK gene variants are linked to congenital kidney and urinary tract anomalies (CAKUT). Our studies confirm DSTYK loss-of-function variants cause CAKUT and neurological disorders, emphasizing large-scale studies for low-penetrance traits.
Area of Science:
- Genetics
- Developmental Biology
- Medical Research
Background:
- Previous research implicated rare DSTYK variants in congenital anomalies of the kidney and urinary tract (CAKUT).
- The precise role, penetrance, and expressivity of DSTYK variants in human disease remain incompletely understood.
Purpose of the Study:
- To clarify the association between DSTYK variants and CAKUT.
- To investigate the penetrance and expressivity of DSTYK variants in both mouse models and human cohorts.
- To explore potential links between DSTYK variants and other neurological disorders.
Main Methods:
- Phenotypic characterization of Dstyk knockout mice across three inbred backgrounds.
- Re-analysis of a human family with a DSTYK splice-site variant (SSV).
- Annotation of DSTYK loss-of-function (LOF) and SSVs in individuals with CAKUT, epilepsy, or amyotrophic lateral sclerosis, and controls.
- Exploratory phenome-wide association study (PheWAS) using UK Biobank data.
Main Results:
- Dstyk knockout mice exhibited 20-40% penetrance of obstructive uropathy, varying by genetic background.
- The studied DSTYK SSV in humans showed low penetrance (43.8%) with no identified alternative genetic causes for CAKUT.
- A significant excess burden of DSTYK LOF variants was observed in individuals with CAKUT and epilepsy compared to controls.
- PheWAS results supported an association between DSTYK variants and neurological disorders.
Conclusions:
- These findings provide strong evidence supporting the causality of DSTYK LOF variants in CAKUT and neurological conditions.
- The study highlights the critical need for large-scale sequencing initiatives to accurately determine gene and variant causality for low-penetrance, common traits.
Related Concept Videos
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
In-vitro Mutagenesis

